Saitama Medical University Hospital

Saitama 350-0495

1 studies enrolling now · 5 studies all time

What they study most

Atypical Hemolytic Uremic Syndrome, Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, Crohn's Disease, Diabetic Macular Edema, Follicular Lymphoma, Hemi-retinal Vein Occlusion, Marginal Zone Lymphoma, Neovascular Age-related Macular Degeneration, Primary IgA Nephropathy, Retinal Vein Occlusion

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression — Recruiting now
• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) — Running, not enrolling
• A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products — Running, not enrolling
• A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. — Running, not enrolling